Company Data
Prime Medicine Inc.
Ticker
PRME
Current Price
$2.965 -5.27%
Market Cap
$388.9M
Price Target
Refer to Report
Volume
804.4K
52wk Range
$2.25 - $9.77
Overview
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs.